Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.
第一作者:
C,Nickenig
第一单位:
Department of Internal Medicine III, Ludwig-Maximilians University, Munich Grosshadern.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡莫司汀(Carmustine);苯丁酸氮芥(Chlorambucil);环磷酰胺(Cyclophosphamide);阿糖胞苷(Cytarabine);地塞米松(Dexamethasone);多柔比星(Doxorubicin);依托泊甙(Etoposide);女(雌)性(Female);德国(Germany);造血干细胞动员(Hematopoietic Stem Cell Mobilization);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);淋巴瘤, 滤泡性(Lymphoma, Follicular);淋巴瘤, 膜细胞(Lymphoma, Mantle-Cell);男(雄)性(Male);美法仑(Melphalan);中年人(Middle Aged);米托蒽醌(Mitoxantrone);泼尼松龙(Prednisolone);泼尼松(Prednisone);前瞻性研究(Prospective Studies);存活率(Survival Rate);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.1093/annonc/mdl348
PMID
17071931
发布时间
2020-07-11
- 浏览11
Annals of oncology
136-142页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



